TrialTrials2016

TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.

Matthew B Laurens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.